Anavex Life Sciences Corp (AVXL)

[sokol]

This Slide 9, with the Hampel 2019 reference, is entitled: ANAVEX®2-73 Selective Sigma-1 Receptor (SIGMAR1) Agonist Demonstrated Improved MMSE1 and ADCS-ADL2 Scores in Phase 2a AD Study through 148 Weeks

Slide 9 shows:

Adjusted change in MMSE1 (±SE) - p-value < 0.0001 and Adjusted change in ADCS-AD
2 (±SE) - p-value < 0.0008

Encouraging.